Floatz logo

Certepetide

Peritoneal Carcinomatosis

University of California, San Diegoprotein_peptidePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

32 Active assets in the Peritoneal Carcinomatosis cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Ciusss de L'Est de l'Île de Montréal
Phase 3BB
Eloxatin
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 3BB
Irinotecan
Catharina Ziekenhuis Eindhoven
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 3BB
MITOMYCIN C
H. Lee Moffitt Cancer Center and Research Institute
Phase 4BB

View all 41 →

Same molecule, other indications

Certepetide is also rated in:

pancreatic ductal adenocarcinomaDormant
CCC
Indicative ·
51 / 100
View asset →
malignant pancreatic neoplasmDormant
CCC
Indicative ·
51 / 100
View asset →
gallbladder cancerDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →